The PANEN nomogram: clinical decision support for patients with metastatic pancreatic neuroendocrine neoplasm referred for peptide receptor radionuclide therapy. [PDF]
Singh A +5 more
europepmc +1 more source
Considerations for Establishing Peptide Receptor Radionuclide Therapy: A Nationally Coordinated, Collaborative, and Equitable Service for New Zealand. [PDF]
Steyn R +13 more
europepmc +1 more source
Fibrosis markers as prognostic markers of decline in kidney function in patients with neuroendocrine neoplasms undergoing peptide receptor radionuclide therapy. [PDF]
Stemann Lau T +7 more
europepmc +1 more source
Impact of functionality and grading on survival in pancreatic neuroendocrine tumor patients receiving peptide receptor radionuclide therapy. [PDF]
Mathew A +5 more
europepmc +1 more source
Multicycle Dosimetric Behavior and Dose-Effect Relationships in [<sup>177</sup>Lu]Lu-DOTATATE Peptide Receptor Radionuclide Therapy. [PDF]
Kayal G +7 more
europepmc +1 more source
An ACTH-Producing Neuroendocrine Tumor: Clinical Course of Multidisciplinary Therapy Including Peptide Receptor Radionuclide Therapy - A Case Report. [PDF]
Koizumi T +10 more
europepmc +1 more source
Treatment planning for molecular radiotherapy: potential and prospects [PDF]
Aldridge, Matt +14 more
core
Somatostatin analogs: Future directions [PDF]
Herder, W.W. (Wouter) de +3 more
core +1 more source

